Literature DB >> 31550722

A Clinico-Radiological Study of Cerebral Amyloid Angiopathy-Related Inflammation.

Sarah Coulette1, Dimitri Renard2, Sylvain Lehmann3, Nicolas Raposo4, Caroline Arquizan1, Mahmoud Charif1, Eric Thouvenot2, Anne Wacongne2, Alain Viguier4, Fabrice Bonneville5, Thibaut Allou6, Yassine Boukriche7, Laura Chiper7, Genevieve Blanchet Fourcade8, Audrey Gabelle1,9, Anne Ducros1, Claire Duflos10, Pierre Labauge1, Nicolas Menjot de Champfleur11, Xavier Ayrignac12.   

Abstract

OBJECTIVE: To describe the clinico-radiological features and long-term prognosis in patients with cerebral amyloid angiopathy-related inflammation (CAA-ri).
METHODS: Twenty-eight CAA-ri patients were recruited retrospectively from 6 neurological centers. We recorded the clinico-radiological and biological data, at baseline and during follow-up. Baseline characteristics associated with relapse risk and prognosis were assessed.
RESULTS: Five patients had pathologically confirmed CAA-ri whereas 23 had probable (n = 21) or possible (n = 2) CAA-ri. The mean age was 72 years; main clinical symptoms included confusion (54%), hemiparesis (36%), and aphasia (29%). Cerebral MRI disclosed a brain parenchymal lesion (89%), which was usually multifocal (82%) and bilateral (89%). It was associated with gadolinium enhancement (84%), small ischemic lesions (39%), cortical superficial siderosis (CSS; 50%), and a high number of microbleeds (mean 240 ± 277). An isolated leptomeningeal involvement was observed in 3 patients with pathological confirmation. Despite a favorable initial evolution after treatment, we observed a 42% risk of relapse, mostly within the first year (83%). After a mean follow-up of 2 years, 29% died and 25% had a marked disability. Disseminated CSS was associated with death.
CONCLUSION: Despite an apparently favorable initial evolution, CAA-ri is characterized by a poor prognosis. Diagnostic criteria should consider patients with isolated leptomeningeal involvement.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Cerebral amyloid angiopathy; Cerebral amyloid angiopathy-related inflammation ; Cortical superficial siderosis; Magnetic resonance imaging; Outcome

Mesh:

Year:  2019        PMID: 31550722     DOI: 10.1159/000502832

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  4 in total

1.  Different clinical outcomes between cerebral amyloid angiopathy-related inflammation and non-inflammatory form.

Authors:  L Grangeon; G Quesney; X Ayrignac; D Wallon; M Verdalle-Cazes; S Coulette; D Renard; A Wacongne; T Allou; N Olivier; Y Boukriche; G Blanchet-Fourcade; P Labauge; C Arquizan; S Canaple; O Godefroy; O Martinaud; P Verdure; M Quillard-Muraine; J Pariente; E Magnin; G Nicolas; C Charbonnier; D Maltête; M Formaglio; N Raposo
Journal:  J Neurol       Date:  2022-06-26       Impact factor: 6.682

2.  [Dysphasic seizures due to chronic leptomeningitis : A challenge in differential diagnosis].

Authors:  K Olaciregui Dague; J Pukropski; C Hummel; A Becker; R Surges; T Baumgartner
Journal:  Nervenarzt       Date:  2021-09-29       Impact factor: 1.297

3.  Cerebral Amyloid Angiopathy-related Inflammation Presenting With a Cystic Lesion in Young-onset Alzheimer Disease.

Authors:  John M Ringman; Elizabeth Joe; Nasim Sheikh-Bahaei; Carol Miller; Harry V Vinters; Samuel Guzman; Helena C Chui
Journal:  Alzheimer Dis Assoc Disord       Date:  2021 Jul-Sep 01       Impact factor: 2.703

4.  Cerebral amyloid angiopathy related inflammation: A little known but not to be underestimated disease.

Authors:  Daniela Grasso; Giulia Castorani; Carmela Borreggine; Annalisa Simeone; Roberto De Blasi
Journal:  Radiol Case Rep       Date:  2021-07-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.